The Role of Angiopoietin, Tie-2, and Vascular Endothelial Growth Factor (VEGF) in Sepsis-Induced Multiple Organ Dysfunction Syndrome (MODS)
NCT00908635 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2009-05-27
Summary
This study is designated to determine serum concentrations of inflammatory mediators Ang-1, Ang-2, Ang-1/Ang-2 ratio, and Tie-2 in patients with sepsis-induced MODS and to investigate the association among increased permeability, inflammatory mediators, and these serum mediators in development of organ failure.
Conditions
- Sepsis
- Multiple Organ Dysfunction Syndrome
Sponsors & Collaborators
-
Chang Gung Memorial Hospital
lead OTHER
Principal Investigators
-
Shu-Min Lin, MD · Chang Gung Memorial Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2010-08-31
- Completion
- 2010-08-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Investigate the Activity of Endotoxin in Severe Sepsis
NCT01957254 ·Status: TERMINATED
-
Myeloid-derived Suppressor Cells in Sepsis
NCT03540797 ·Status: UNKNOWN
-
Mitochondrial Function of Immune Cells in Sepsis
NCT01600989 ·Status: COMPLETED
-
Effect of Immunophenotype on Prognosis of Sepsis
NCT05602584 ·Status: UNKNOWN
-
Effect of APC and Epo on the Inflammatory Response During Sepsis
NCT00229034 ·Status: COMPLETED
-
The Impact of Coagulation Disorders on the Diagnosis and Prognosis of Sepsis
NCT05998733 ·Status: UNKNOWN
-
Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis
NCT00430859 ·Status: COMPLETED ·Phase: PHASE2
-
Application of Biomarkers Change to Predict Outcome of Patient With Severe Sepsis
NCT02871895 ·Status: UNKNOWN
-
Efficacy of Mw Vaccine in Treatment of Severe Sepsis
NCT02025660 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Genomics in Infection and Sepsis to Predict Organ Dysfunction and Outcomes in Sepsis
NCT04199962 ·Status: UNKNOWN
-
The Application of SERS and Metabolomics in Sepsis
NCT02213237 ·Status: UNKNOWN
-
Co-inhibitory Molecules on Treg and miR-155-5p in Patients With Sepsis
NCT05126537 ·Status: UNKNOWN
-
The Predictive Value of Hepatocyte Growth Factor and Soluble Receptor s-Met in Sepsis
NCT03340649 ·Status: UNKNOWN
-
Endothelium in Severe Sepsis
NCT00793442 ·Status: COMPLETED
-
Midkine and ACE-Ang II Induced Endothelial Injury in Sepsis
NCT02605681 ·Status: COMPLETED
-
Clinical Characteristics and Risk Factors for In-Hospital Mortality in Surgical Patients With Abdominal Sepsis
NCT06756750 ·Status: COMPLETED
-
Dynamics of Organ Damage and Immune Exhaustion During Sepsis
NCT06817408 ·Status: RECRUITING
-
Comparative Study of the Protein C Pathway in Septic and Non Septic Patients With Organ Failure
NCT00361725 ·Status: TERMINATED
-
Study on the Construction and Application of Early Warning Model of Sepsis in Critically Ill Patients
NCT06904001 ·Status: ENROLLING_BY_INVITATION
-
Gut Microbiome Dysbiosis in Sepsis-induced Coagulopathy
NCT04525677 ·Status: UNKNOWN
-
Adrenomedullin and Outcome in Severe Sepsis and Septic Shock
NCT02393781 ·Status: COMPLETED
-
Immune Profile of Patients With Sepsis
NCT04163705 ·Status: UNKNOWN
-
Pediatric Immune Response to Multi-Organ Dysfunction
NCT04438460 ·Status: COMPLETED ·Phase: NA
-
Effect of Renin-Angiotensin System on Platelet in Patient With Sepsis
NCT03952390 ·Status: COMPLETED
-
Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?
NCT02903082 ·Status: TERMINATED